Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2002
11/28/2002CA2446516A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446510A1 Therapeutic agent for tumor of neural origin
11/28/2002CA2446332A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446316A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446311A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2445010A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/28/2002CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2349123A1 Anionic exchange polymer complexes of buspirone
11/27/2002EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260232A1 Remedies for malignant tumor-concomitant neurosis and azoor or analogous diseases thereof
11/27/2002EP1260221A2 Combination treatment for depression and anxiety
11/27/2002EP1259818A2 Diagnosis and treatment of schizophrenia
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259618A2 Human enzyme molecules
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259609A2 Human schizophrenia gene
11/27/2002EP1259607A2 Protein and gene and their use for diagnosis and treatment of schizophrenia
11/27/2002EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002EP1259550A1 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259505A2 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
11/27/2002EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002EP1259501A2 Method for the preparation of citalopram
11/27/2002EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002EP1259477A1 Aminoadamantane derivatives as therapeutic agents
11/27/2002EP1259282A1 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
11/27/2002EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002EP1259241A1 The use of scopolamine salts
11/27/2002EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002EP1192152B1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
11/27/2002EP1093369B1 Agent with an antidepressive effect comprising pramipexole and sertraline
11/27/2002EP1089744B1 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1017672B1 New npy antagonists
11/27/2002EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0960110B8 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS
11/27/2002EP0920330B1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
11/27/2002EP0912554B1 Indoline derivatives useful as 5-ht-2c receptor antagonists
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382145A Remedies for neuropathic pain and model animals of neuropathic pain
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1382051A Injectable bupernorphine microparticle compositions and their use
11/27/2002CN1382047A Neurotherapeutic clavulanate composition and method
11/27/2002CN1382037A Oral solution containing galanthamine and sweetening agent
11/27/2002CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/27/2002CN1381455A Method for synthe sizing (3aS)-5, 5-dioxo-2, 3, 3a, 4-tetrahydric-1H-pyrrolo [2,1-c] [1,2,4] benzodiazine
11/27/2002CN1381449A Aralkylone pipeazine derivative and its application
11/27/2002CN1381448A Aralkylformylalkyl piperazine derivative and its application as brain nerve protector
11/27/2002CN1381242A Capsule for treating depression
11/27/2002CN1381236A Medicinal composition containing baicalin and caffoeoylchinic acid
11/27/2002CN1094929C Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/27/2002CN1094926C Antimer pure acetacetates, its preparation method and use
11/27/2002CN1094761C Medicine for treatment of child attentional deficit hyperactivity disorder (ADHD)
11/27/2002CN1094757C Isobutyl gamma-amino-butyric acid and its derivatives for treatment of pain
11/27/2002CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt
11/26/2002US6486350 Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
11/26/2002US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
11/26/2002US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002US6486321 Epoxidation; quaternization
11/26/2002US6486214 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
11/26/2002US6486210 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents
1 ... 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 ... 1833